News
On Nov. 26, 2019, ChemoCentryx issued a press release announcing that the Advocate trial met both of its primary endpoints, saying Tavneos showed noninferiority of disease remission at 26 weeks and ...
Investor's Business Daily on MSN52m
Stock Market Keeps Hitting Highs Amid Tesla, Google, Trade Deals: Weekly ReviewThe S&P 500 and Nasdaq hit fresh highs last week, aided by Trump trade deals. Google, ServiceNow and GE Vernova were earnings winners. Tesla tumbled.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback